FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Betsey Herpin

Research Profile

Disorders

HIV Infections

Anatomy

Chemicals & Drugs

Living Beings

Procedures

Highly Active Antiretroviral Therapy

Physiology

Organizations

National Institute of Allergy and Infectious Diseases (U.S.)

Concepts & Ideas

Co-author Network

Publications

TOP 3
Heather Bridge; Mary Smolskis; Peter Bianchine; Dennis O Dixon; Grace Kelly; Betsey Herpin; Jorge Tavel
Development and implementation of clinical trial protocol templates at the National Institute of Allergy and Infectious Diseases.
Richard A Morgan; Robert E Walker; Charles S Carter; Ven Natarajan; Jorge A Tavel; Chris Bechtel; Betsey Herpin; Linda Muul; Zhili Zheng; Shyla Jagannatha; Bruce A Bunnell; Vicki Fellowes; Julia A Metcalf; Randy Stevens; Michael Baseler; Susan F Leitman; Elizabeth J Read; R. Michael Blaese; H Clifford Lane
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.
Amy C Lu; Elizabeth C Jones; Catherine Chow; Kirk D Miller; Betsey Herpin; Diane Rock Kress; Julia A Metcalf; H Clifford Lane; Joseph A Kovacs
Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Betsey Herpin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Heather Bridge; Mary Smolskis; Peter Bianchine; Dennis O Dixon; Grace Kelly; Betsey Herpin; Jorge Tavel
Development and implementation of clinical trial protocol templates at the National Institute of Allergy and Infectious Diseases.
Clinical trials (London, England) 2009;6(4):386-91.
2005: Richard A Morgan; Robert E Walker; Charles S Carter; Ven Natarajan; Jorge A Tavel; Chris Bechtel; Betsey Herpin; Linda Muul; Zhili Zheng; Shyla Jagannatha; Bruce A Bunnell; Vicki Fellowes; Julia A Metcalf; Randy Stevens; Michael Baseler; Susan F Leitman; Elizabeth J Read; R. Michael Blaese; H Clifford Lane
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.
Human gene therapy 2005;16(9):1065-74.
2003: Amy C Lu; Elizabeth C Jones; Catherine Chow; Kirk D Miller; Betsey Herpin; Diane Rock Kress; Julia A Metcalf; H Clifford Lane; Joseph A Kovacs
Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34(3):299-303.
2002: Mark Dybul; Bertha Hidalgo; Tae-Wook Chun; Michael Belson; Stephen A Migueles; J Shawn Justement; Betsey Herpin; Cheryl Perry; Claire W Hallahan; Richard Davey; Julia A Metcalf; Mark Connors; Anthony Fauci
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.
The Journal of infectious diseases 2002;185(1):61-8.
2001: Joseph A Kovacs; Richard A Lempicki; Igor A Sidorov; Joseph W Adelsberger; Betsey Herpin; Julia A Metcalf; Irini Sereti; Michael A Polis; Richard Davey; Jorge A Tavel; Judith Falloon; Randy Stevens; Laurie Lambert; Robin L Dewar; DJ Schwartzentruber; M R Anver; Michael Baseler; Henry Masur; Dimiter S Dimitrov; H Clifford Lane
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
The Journal of experimental medicine 2001;194(12):1731-41.
2001: Irini Sereti; Betsey Herpin; Julia A Metcalf; R Stevens; Michael Baseler; Claire W Hallahan; Joseph A Kovacs; Richard Davey; H Clifford Lane
CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients.
AIDS (London, England) 2001;15(14):1765-75.
2001: Kirk D Miller; K Spooner; Betsey Herpin; Diane Rock Kress; Julia A Metcalf; Richard Davey; Judith Falloon; Joseph A Kovacs; Michael A Polis; Robert E Walker; Henry Masur; H Clifford Lane
Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.
Clinical immunology (Orlando, Fla.) 2001;99(1):30-42.
2000: Mark Dybul; G Mercier; Michael Belson; Claire W Hallahan; Shuying Liu; C Perry; Betsey Herpin; Linda Ehler; Richard Davey; Julia A Metcalf; JoAnn M Mican; Robert A Seder; Anthony Fauci
CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1685-91.
1999: Daryl T-Y Lau; K D Miller; Jill Detmer; Janice A Kolberg; Betsey Herpin; Julia A Metcalf; Richard Davey; Jay H Hoofnagle
Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.
The Journal of infectious diseases 1999;180(4):1334-7.
1998: Robert E Walker; C S Carter; Linda Muul; Ven Natarajan; Betsey Herpin; Susan F Leitman; HARVEY KLEIN; Craig A Mullen; Julia A Metcalf; Michael Baseler; Judith Falloon; Richard Davey; Joseph A Kovacs; Michael A Polis; Henry Masur; R. Michael Blaese; H Clifford Lane
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.
Nature medicine 1998;4(7):852-6.